Inicio › Cáncer del colon y del recto › Washington
Ensayos clínicos de Cáncer del colon y del recto en Washington
48 estudios sobre Cáncer del colon y del recto buscan participantes en Washington.
Ciudades en Washington
- Seattle35 estudios
- Tacoma10 estudios
- Spokane8 estudios
- Kirkland8 estudios
- Renton8 estudios
- Vancouver6 estudios
- Everett5 estudios
- Kennewick5 estudios
- Bellingham5 estudios
- Walla Walla4 estudios
- Spokane Valley4 estudios
- Longview4 estudios
Texto oficial del estudio (inglés)
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Virginia Mason Medical Center, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07659795A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Swedish Cancer Institute Medical Oncology, Edmonds
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06270706Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
- Vista Oncology - West Olympia_Olympia_2, Olympia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07775287A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Virginia Mason Medical Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Medical Oncology Associates, Spokane
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07503808The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- y 17 más
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07018869Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06324357Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Spokane
- Clinical Study Site, Tacoma
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07228832Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- y 20 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Kaiser Permanente Bellevue Medical Center, Bellevue
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Swedish Cancer Institute-Edmonds, Edmonds
- y 8 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06418204A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Swedish Cancer Institute Edmonds, Edmonds
- Swedish Cancer Institute Issaquah, Issaquah
- Swedish Cancer Institute, Seattle
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06662786A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Providence Regional Cancer System, Lacey
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06750094A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Swedish Cancer Institute, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06663319Family Communications After Genetic Testing
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- y 18 más
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07143487Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Valley Medical Center, Renton
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT05673148A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Georgetown University Medical Center, Georgetown
- Cancer Care Northwest, Spokane
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT03526835A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Vista Oncology Inc Ps, Olympia
- Virginia Mason Medical Center, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07284849A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- University Of Washington /ID# 271298, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06820463A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Wenatchee Valley Hospital and Clinics, Wenatchee
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06330064Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Fred Hutchinson Cancer Center, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0491, Edmonds
- Local Institution - 0253, Seattle
- Local Institution - 0629, Spokane
- y 1 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07221357A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Fred Hutchinson Cancer Center / University of Washington, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT04657068A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Wenatchee
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06885034A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- University Of Washington /ID# 281451, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07525206A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Swedish Cancer Institute, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT06992258Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Northwest Medical Specialties, PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Medical Center - Edmonds, Edmonds
- y 13 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222800The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Northwest Medical Specialties, Tacoma
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06047379Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06445062Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
- Benaroya Research Institute at Virginia Mason, Seattle
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT06995924Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- University of Washington, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT05410977A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT07066657Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- University Of Washington, Seattle
ReclutandoFase 1
Edades de 18 a 100 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06562192A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Providence Regional Cancer Partnership, Everett
- Providence Regional Medical Center Everett, Everett
- Northwest Cancer Specialists, P.C., Vancouver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05253651A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Medstar Speciality Hospital, Northwest
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT06562543A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06822530A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.